PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16961715-0	2006	Relationship between neurokinin 2 receptor gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced asthma.	Toluene 2,4-Diisocyanate	131-151	vascular endothelial growth factor A	Homo sapiens	72-106	
19624533-0	2009	Toluene diisocyanate enhances human bronchial epithelial cells" permeability partly through the vascular endothelial growth factor pathway.	Toluene 2,4-Diisocyanate	0-20	vascular endothelial growth factor A	Homo sapiens	96-130	
19624533-9	2009	ELISA showed that TDI significantly induces VEGF release from HBE135-E6E7 cells.	Toluene 2,4-Diisocyanate	18-21	vascular endothelial growth factor A	Homo sapiens	44-48	
22314196-9	2012	Furthermore, toluene diisocyanate (TDI) increased VEGF production and secretion from this epithelial cells by suppression of 1,25-dihydroxycholecalciferol [1,25(OH)(2)D(3)] production.	Toluene 2,4-Diisocyanate	13-33	vascular endothelial growth factor A	Homo sapiens	50-54	
22314196-9	2012	Furthermore, toluene diisocyanate (TDI) increased VEGF production and secretion from this epithelial cells by suppression of 1,25-dihydroxycholecalciferol [1,25(OH)(2)D(3)] production.	Toluene 2,4-Diisocyanate	35-38	vascular endothelial growth factor A	Homo sapiens	50-54	
18250044-0	2008	[Toluene diisocyanate increases vascular endothelial growth factor expression in human bronchial epithelial cells].	Toluene 2,4-Diisocyanate	1-21	vascular endothelial growth factor A	Homo sapiens	32-66	
18250044-1	2008	OBJECTIVE: To investigate the effect of toluene diisocyanate (TDI) on the expression of vascular endothelial growth factor (VEGF) in human bronchial epithelial (HBE) cells.	Toluene 2,4-Diisocyanate	40-60	vascular endothelial growth factor A	Homo sapiens	88-122	
18250044-1	2008	OBJECTIVE: To investigate the effect of toluene diisocyanate (TDI) on the expression of vascular endothelial growth factor (VEGF) in human bronchial epithelial (HBE) cells.	Toluene 2,4-Diisocyanate	40-60	vascular endothelial growth factor A	Homo sapiens	124-128	
18250044-1	2008	OBJECTIVE: To investigate the effect of toluene diisocyanate (TDI) on the expression of vascular endothelial growth factor (VEGF) in human bronchial epithelial (HBE) cells.	Toluene 2,4-Diisocyanate	62-65	vascular endothelial growth factor A	Homo sapiens	88-122	
18250044-1	2008	OBJECTIVE: To investigate the effect of toluene diisocyanate (TDI) on the expression of vascular endothelial growth factor (VEGF) in human bronchial epithelial (HBE) cells.	Toluene 2,4-Diisocyanate	62-65	vascular endothelial growth factor A	Homo sapiens	124-128	
18250044-9	2008	CONCLUSION: TDI induces significant increase in VEGF expression in HBE cells, and VEGF overexpression may play an important role in the pathogenesis of TDI-induced asthma.	Toluene 2,4-Diisocyanate	12-15	vascular endothelial growth factor A	Homo sapiens	48-52	
18250044-9	2008	CONCLUSION: TDI induces significant increase in VEGF expression in HBE cells, and VEGF overexpression may play an important role in the pathogenesis of TDI-induced asthma.	Toluene 2,4-Diisocyanate	152-155	vascular endothelial growth factor A	Homo sapiens	82-86	
16961715-7	2006	CONCLUSION: The NK2R 7853GG genotype may contribute to increased serum VEGF levels, which result in airway inflammation after TDI exposure.	Toluene 2,4-Diisocyanate	126-129	vascular endothelial growth factor A	Homo sapiens	71-75	
27884393-1	2017	BACKGROUND: In our previous studies, we have indentified that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) can alleviate toluene diisocyanate-induced airway epithelial barrier disruption and we also found that vascular endothelial growth factor (VEGF) derived from airway epithelials cells could disrupt epithelial barrier.	Toluene 2,4-Diisocyanate	115-135	vascular endothelial growth factor A	Homo sapiens	204-238	
27884393-1	2017	BACKGROUND: In our previous studies, we have indentified that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) can alleviate toluene diisocyanate-induced airway epithelial barrier disruption and we also found that vascular endothelial growth factor (VEGF) derived from airway epithelials cells could disrupt epithelial barrier.	Toluene 2,4-Diisocyanate	115-135	vascular endothelial growth factor A	Homo sapiens	240-244	
15201500-0	2004	Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.	Toluene 2,4-Diisocyanate	92-112	vascular endothelial growth factor A	Homo sapiens	29-63	
15201500-0	2004	Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.	Toluene 2,4-Diisocyanate	92-112	vascular endothelial growth factor A	Homo sapiens	65-69	
15201500-0	2004	Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.	Toluene 2,4-Diisocyanate	114-117	vascular endothelial growth factor A	Homo sapiens	29-63	
15201500-0	2004	Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.	Toluene 2,4-Diisocyanate	114-117	vascular endothelial growth factor A	Homo sapiens	65-69	
15201500-2	2004	This study aimed to evaluate the role of VEGF in immediate bronchoconstriction induced by TDI inhalation, and in chronic TDI-asthma patients.	Toluene 2,4-Diisocyanate	90-93	vascular endothelial growth factor A	Homo sapiens	41-45